Ultragenyx Pharmaceutical Inc. - RARE

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Nov 13, 2026 SCHEDULE 13G/A AQR Capital Management, LLC 0.64% 633,393 View
Nov 13, 2026 SCHEDULE 13G/A AQR Capital Management Holdings, LLC 0.64% 633,393 View
Nov 10, 2026 SCHEDULE 13G STATE STREET CORPORATION 7.6% 7,538,078 View
Nov 10, 2026 SCHEDULE 13G SSGA FUNDS MANAGEMENT, INC. 5.4% 5,318,630 View
Oct 30, 2026 SCHEDULE 13G/A Vanguard Portfolio Management 8.6% 8,481,266 View
Oct 20, 2026 SCHEDULE 13G Madison Avenue International LP 6.4% 6,307,798 View
Oct 20, 2026 SCHEDULE 13G Madison Avenue Partners, LP 6.4% 6,307,798 View
Oct 20, 2026 SCHEDULE 13G EMAI Management, LLC 6.4% 6,307,798 View
Oct 20, 2026 SCHEDULE 13G Madison Avenue GP, LLC 6.4% 6,307,798 View
Oct 20, 2026 SCHEDULE 13G Caraway Jackson Investments LLC 6.4% 6,307,798 View
Oct 20, 2026 SCHEDULE 13G Eli Samaha 6.4% 6,307,798 View
Aug 14, 2026 SCHEDULE 13G RTW Investments, LP 7.9% 7,796,895 View
Aug 14, 2026 SCHEDULE 13G Roderick Wong 7.9% 7,796,895 View
Aug 13, 2026 SCHEDULE 13G AQR Capital Management, LLC 6.66% 6,560,809 View
Aug 13, 2026 SCHEDULE 13G AQR Capital Management Holdings, LLC 6.66% 6,560,809 View
Jul 31, 2026 SCHEDULE 13G/A Vanguard Portfolio Management 6.95% 6,853,427 View
Jul 31, 2026 SCHEDULE 13G Vanguard Capital Management 5.13% 5,058,419 View
Jul 30, 2026 SCHEDULE 13G/A BlackRock, Inc. 8.3% 8,141,384 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.